Consumo de antimicrobianos en hospital de tercer nivel durante el periodo 2020-2022.

Abstract

Introduction: The purpose of this study is to investigate the consumption demand of antimicrobials in third world medical facilities during the 2020- 2022 period. Antimicrobials is a pharmaceutical produced agent that kills or stops of the growth of microorganisms and commonly used to treat pathological infections. Objective: To quantify the consumption of antimicrobials based on AWaRe database from World Health Organization during the 2021-2022 period. Methodology: A retrospective study was carried out, using the quantitative method and cross-sectional design. The investigation excluded non antimicrobial medication. To collect and run statistical analysis on antimicrobial use, Microsoft Excel was utilized. Results: The data indicated that the following antimicrobial medications were in demand during 2021-2022: Cefepime 0.44%, Ceftazidime 0.19%, Ceftazidime-Avibactam 0.65%, Ceftriaxone 1.54%, Ciprofloxacin 6.25%, Clarithromycin 0.52%, Colistin 15.19%, Ertapenem 0.02%, Fosfomycin 3.81%, Imipenem+Cilastatina 0.97%, Linezolid 0.11%, Meropenem 45.88%, Piperacillin-Tazobactam 24.44%. Conclusion: Health care personnel knowledge on the use of antibiotic, the repeated misuse of the medication leads to nosocomial infection. Educating the patient can avoid selfmedication or over-reliance that will reduce antimicrobial resistance.